Your browser doesn't support javascript.
loading
Errate: Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity.
Wang, Jiaxing; Huang, Fakun; Jiang, Caiyun; Chi, Pan.
Afiliación
  • Wang J; Department of General Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, China (mainland).
  • Huang F; Department of Gastroenterological Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China (mainland).
  • Jiang C; Department of Colorectal Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, China (mainland).
  • Chi P; Department of General Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, China (mainland).
Med Sci Monit ; 29: e941845, 2023 07 20.
Article en En | MEDLINE | ID: mdl-37470125
ABSTRACT
It was brought to our attention by the authors that Figures 5A and 6A contained errors. The correct version of Figures 5A and 6A are provided below. The corrected figures do not change the overall findings of the study. Reference Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit, 2020; 26 e915854. DOI 10.12659/MSM.915854.